Literature DB >> 12142103

In-stent restenosis in small coronary arteries: impact of strut thickness.

Carlo Briguori1, Cristiano Sarais, Paolo Pagnotta, Francesco Liistro, Matteo Montorfano, Alaide Chieffo, Fabio Sgura, Nicola Corvaja, Remo Albiero, Goran Stankovic, Costantinos Toutoutzas, Erminio Bonizzoni, Carlo Di Mario, Antonio Colombo.   

Abstract

UNLABELLED: OBJECTIVES; We sought to evaluate whether strut thickness may impact the restenosis rate after stent implantation in small coronary arteries.
BACKGROUND: Small vessel size (<3.0 mm) is an independent risk factor for the occurrence of in-stent restenosis. It has been reported that vessel damage induced during stent deployment is an important factor in restenosis.
METHODS: From our database, we selected all patients who had successful stenting in small native vessels, with angiographic follow-up available, between March 1996 and April 2001. The strut was defined as thin when <0.10 mm and thick when > or = 0.10 mm. According to these criteria, we identified two subgroups: a thin group and a thick group.
RESULTS: A total of 821 (57%) of the 1,447 patients had angiographic follow-up available and were included in the analysis. The thin group included 400 patients with 505 lesions. The thick group included 421 patients with 436 lesions. The restenosis rate was 28.5% in the thin group and 36.6% in the thick group (p = 0.009; odds ratio [OR] 1.44, 95% confidence interval [CI] 1.09 to 1.90). The study group was classified into three subgroups according to the reference vessel diameter: < or = 2.50 mm, 2.51 to 2.75 mm and 2.76 to 2.99 mm. Strut thickness influenced the restenosis rate only in the subgroup with a reference vessel diameter between 2.76 and 2.99 mm, with rates of 23.5% in the thin group and 37% in the thick group (p = 0.006). By logistic regression analysis, predictors of restenosis were stent length (OR 1.03, 95% CI 1.01 to 1.04; p = 0.001), strut thickness (OR 1.68, 95% CI 1.23 to 2.29; p = 0.001) and diabetes mellitus (OR 2.10, 95% CI 1.21 to 3.68; p = 0.007).
CONCLUSIONS: This study supports that strut thickness is an independent predictor of restenosis in coronary arteries with a reference diameter of 2.75 to 2.99 mm.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12142103     DOI: 10.1016/s0735-1097(02)01989-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  40 in total

1.  One-year clinical follow-up of a registry evaluating a percutaneous revascularisation strategy combining a pre-specified simple selection process with the use of a new thin-strut bare cobalt-chromium stent.

Authors:  P R Stella; G Pavlakis; P Agostoni; H M Nathoe; S Hoseyni Guyomi; B J Hamer; T X Wildbergh; P A Doevendans; E Van Belle
Journal:  Neth Heart J       Date:  2010-10       Impact factor: 2.380

2.  Cobalt-chromium stents in long lesions of large vessels: clinical and angiographic results.

Authors:  Iñigo Lozano; Carlos Cuellas; Pablo Avanzas; Armando Pérez de Prado; Concepción Suárez; Juan Rondan; Daehyun Lee; Jesus M de la Hera; Felipe Fernández; César Morís
Journal:  Tex Heart Inst J       Date:  2011

3.  Development of sutureless vascular connecting system for easy implantation of small-caliber artificial grafts.

Authors:  Osamu Sakai; Yasuhide Nakayama; Yasushi Nemoto; Yoshihiro Okamoto; Taiji Watanabe; Keiichi Kanda; Hitoshi Yaku
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

4.  First in-human randomized comparison of an anodized niobium stent versus a standard stainless steel stent--an intravascular ultrasound and angiographic two-center study: the VELA study.

Authors:  F Beier; M Gyöngyösi; T Raeder; E von Eckardstein-Thumb; W Sperker; P Albrecht; C Spes; D Glogar; H Mudra
Journal:  Clin Res Cardiol       Date:  2006-07-03       Impact factor: 5.460

5.  Determination of the influence of stent strut thickness using the finite element method: implications for vascular injury and in-stent restenosis.

Authors:  Houman Zahedmanesh; Caitríona Lally
Journal:  Med Biol Eng Comput       Date:  2009-02-03       Impact factor: 2.602

Review 6.  The development of carotid stent material.

Authors:  Dongsheng He; Wenhua Liu; Tao Zhang
Journal:  Interv Neurol       Date:  2015-03

7.  Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial.

Authors:  Rosaly A Buiten; Eline H Ploumen; Paolo Zocca; Carine J M Doggen; Liefke C van der Heijden; Marlies M Kok; Peter W Danse; Carl E Schotborgh; Martijn Scholte; Frits H A F de Man; Gerard C M Linssen; Clemens von Birgelen
Journal:  JAMA Cardiol       Date:  2019-07-01       Impact factor: 14.676

8.  Comparison of neointimal hyperplasia and peri-stent vascular remodeling after implantation of everolimus-eluting versus sirolimus-eluting stents: intravascular ultrasound results from the EXCELLENT study.

Authors:  Young-Guk Ko; Dong-Ho Shin; Jung-Sun Kim; Byeong-Keuk Kim; Donghoon Choi; Myeong-Ki Hong; Hyeon-Cheol Gwon; Taehoon Ahn; In-Ho Chae; Jung-Han Yoon; Hyo-Soo Kim; Yangsoo Jang
Journal:  Int J Cardiovasc Imaging       Date:  2013-03-03       Impact factor: 2.357

Review 9.  Small coronary vessel angioplasty: outcomes and technical considerations.

Authors:  Sudhir Rathore
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

10.  Cobalt-chrome MULTI-LINK VISION-stent implantation in diabetics and complex lesions: results from the DaVinci-Registry.

Authors:  Holger M Nef; Helge Möllmann; Michael Weber; Wolfgang Auch-Schwelk; Tassilo Bonzel; Joanis Varelas; Thomas K Nordt; Joachim Schofer; Hans-Heinrich Minden; Jürgen Stumpf; Steffen Schneider; Albrecht Elsässer; Christian W Hamm
Journal:  Clin Res Cardiol       Date:  2009-08-21       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.